Related references
Note: Only part of the references are listed.Prognostic value of response after upfront therapy for acute GVHD
R. M. Saliba et al.
BONE MARROW TRANSPLANTATION (2012)
Graft-versus-Host Disease Treatment: Predictors of Survival
John E. Levine et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
The best endpoint for acute GVHD treatment trials
Margaret L. MacMillan et al.
BLOOD (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
Daniel R. Couriel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
A biomarker panel for acute graft-versus-host disease
Sophie Paczesny et al.
BLOOD (2009)
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
Amin M. Alousi et al.
BLOOD (2009)
Prophylaxis regimens for GVHD: systematic review and meta-analysis
R. Ram et al.
BONE MARROW TRANSPLANTATION (2009)
Study design and endpoints in graft-versus-host disease
Paul J. Martin
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Serum Interleukin-6 Predicts the Development of Multiple Symptoms at Nadir of Allogeneic Hematopoietic Stem Cell Transplantation
Xin Shelley Wang et al.
CANCER (2008)
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
John E. Levine et al.
BLOOD (2008)
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease
David M. Hockenbery et al.
BLOOD (2007)
Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials
S. Z. Pavletic et al.
BONE MARROW TRANSPLANTATION (2006)
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens
Wendy M. Leisenring et al.
BLOOD (2006)
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial
SJ Lee et al.
BLOOD (2004)
Share Paper
